Christopher Aston to Cholesterol, LDL
This is a "connection" page, showing publications Christopher Aston has written about Cholesterol, LDL.
Connection Strength
0.104
-
Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis. 1993 Jan 25; 98(2):201-11.
Score: 0.026
-
Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res Clin Pract. 2008 Oct; 82(1):e5-7.
Score: 0.019
-
Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia. 2006 Oct; 49(10):2488-98.
Score: 0.017
-
Plasma lipoprotein(a) distribution and its correlates among Samoans. Hum Biol. 2000 Apr; 72(2):321-36.
Score: 0.011
-
Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol. 1999; 16(2):205-22.
Score: 0.010
-
Quantitative effects of the apolipoprotein E polymorphism in a biracial sample of 9-10-year-old girls. Atherosclerosis. 1996 Sep 27; 126(1):35-42.
Score: 0.008
-
The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 1995 Jan 20; 112(2):145-59.
Score: 0.007
-
Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals. Atherosclerosis. 1991 Nov; 91(1-2):25-34.
Score: 0.006